Novel blood based test that identifies the genetic mutations occurring in NSCLC patients in approximately 3 days could result in faster initiation of highly individualized therapy with better outcomes feel the team of scientists at Biodesix Inc who invented this test.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer